Your browser doesn't support javascript.
Follow-up study on COVID-19 survivors one year after discharge from hospital.
Zhao, Yumiao; Yang, Chunxia; An, Xiaocai; Xiong, Yajun; Shang, Yaomin; He, Jiarong; Qiu, Yan; Zhang, Ning; Huang, Lisha; Jia, Junli; Xu, Qinfu; Zhang, Long; Zhao, Junjie; Pei, Guangzhong; Luo, Hong; Wang, Jun; Li, Qingquan; Gao, Yanfeng; Xu, Aiguo.
  • Zhao Y; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450051, China.
  • Yang C; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450051, China.
  • An X; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450051, China.
  • Xiong Y; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450051, China.
  • Shang Y; Department of Respiration, Henan Provincial Chest Hospital, Zhengzhou 450003, China.
  • He J; Department of Respiration, The Fifth People's Hospital of Xinyang, Xinyang 464000, China.
  • Qiu Y; Department of Respiration, The Fifth People's Hospital of Xinyang, Xinyang 464000, China.
  • Zhang N; Clinical Laboratory, The Fifth People's Hospital of Xinyang, Xinyang 464000, China.
  • Huang L; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450051, China.
  • Jia J; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450051, China.
  • Xu Q; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450051, China.
  • Zhang L; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450051, China.
  • Zhao J; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450051, China.
  • Pei G; Department of Neurology, Guangshan People's Hospital. Xinyang 465400, China.
  • Luo H; Department of Respiratory and Critical Care Medicine, Guangshan People's Hospital, Xinyang 465400, China.
  • Wang J; Department of Infectious Diseases, Luoshan People's Hospital, Xinyang 465400, China.
  • Li Q; Department of Respiratory and Critical Care Medicine, Xixian People's Hospital, Xinyang 464200, China. Electronic address: sm65070322@163.com.
  • Gao Y; School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China. Electronic address: gaoyf29@mail.sysu.edu.cn.
  • Xu A; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450051, China. Electronic address: aiguoxu@zzu.edu.cn.
Int J Infect Dis ; 112: 173-182, 2021 Nov.
Article in English | MEDLINE | ID: covidwho-1654534
ABSTRACT

OBJECTIVE:

To evaluate the long-term consequences of COVID-19 survivors one year after recovery, and to identify the risk factors associated with abnormal patterns in chest imaging manifestations or impaired lung function.

METHODS:

COVID-19 patients were recruited and prospectively followed up with symptoms, health-related quality of life, psychological questionnaires, 6-minute walking test, chest computed tomography (CT), pulmonary function tests, and blood tests. Multivariable logistic regression models were used to evaluate the association between the clinical characteristics and chest CT abnormalities or pulmonary function.

RESULTS:

Ninety-four patients with COVID-19 were recruited between January 16 and February 6, 2021. Muscle fatigue and insomnia were the most common symptoms. Chest CT scans were abnormal in 71.28% of participants. The results of multivariable regression showed an increased odds in age. Ten patients had diffusing capacity of the lung for carbon monoxide (DLCO) impairment. Urea nitrogen concentration on admission was significantly associated with impaired DLCO. IgG levels and neutralizing activity were significantly lower compared with those in the early phase.

CONCLUSIONS:

One year after hospitalization for COVID-19, a cohort of survivors were mainly troubled with muscle fatigue and insomnia. Pulmonary structural abnormalities and pulmonary diffusion capacities were highly prevalent in surviving COVID-19 patients. It is necessary to intervene in the main target population for long-term recovery.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Int J Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: J.ijid.2021.09.017

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Int J Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: J.ijid.2021.09.017